UK Clinical Trial Recruitment Declines as China Leads Across Trial Phases
Thursday, 5 November 2026, 04:14
UK Clinical Trial Activity Declines in 2025/26
Phase I and Phase II trial initiations in the UK fell in 2025/26, while China continued to grow its clinical trial activity. China became the global leader across all trial phases, according to the source report.
What the change may mean
- UK trial initiations declined in the early phases covered by the report.
- China’s activity continued to increase, placing it first globally across trial phases.
- The available description does not provide trial counts, causes, or country-level comparisons.
The reported shift highlights a change in the distribution of clinical research activity. Consult the original source for further data and context on the call for urgent action.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.